|Issue Date||31/12 - 03/01|
|Issue Size||₹3.12 Cr|
|Market Lot||6000 Shares|
|Shares on Offer||1,416,000|
|Subject to Sauda||N/A|
The Company was incorporated on November 06, 2018, under the provisions of the Companies Act, 2013 by Registrar of Companies, Kanpur. On March 01, 2019, the company took over the entire running business of M/s Gian Pathology and XRays, a proprietorship concern of the promoter Mr. Arun Kumar Gupta with a view to providing diagnostic and related healthcare tests and services.[ A firm, which was formed in 1995, converted into the company in 2018 to bring IPO ]
They are primarily engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. They provide a broad range of diagnostic and related healthcare tests and services such as patient diagnosis services and prevention and wellness diagnosis services to its patients and healthcare providers. The customers include individual patients, hospitals, other healthcare providers and corporate customers.
They offer a broad range of approximately 1,344 tests as of March 31, 2019, it includes various tests ranging from biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology and radiology services.They intend to utilize the proceeds of the Issue to meet the following objectives..
Incorporated in 2018, Kanpur (UP) based Gian Life Care Limited is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers.
The company offers over 1,344 tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services.
Gian Life is NABL accredited and ISO 9001:2015 certified company. It has 59 full-time employees.
The Issue includes a fresh Issue of up to 14,16,000 Equity Shares of the Company at an Issue Price of Rs. 22.00 per Equity Share.
Mr. Arun Kumar Gupta is the promoter of the company, and he has completed his degree in Pathology from G.S.V.M. Medical College in Kanpur. Under his guidance and efforts the laboratory has taken the shape of a big diagnostic center which has its 2 branches across Kanpur and collection centers in its adjoining districts. His knowledge and understanding have helped us foster a reputation among medical practitioners, patients and other healthcare providers as a timely, accurate, convenient and cost-effective laboratory testing services.
The Company was incorporated as a public limited company under the Companies Act, 2013 on November 06, 2018, and pursuant to incorporation have taken over the business of Gian Pathology and X Rays on March 01, 2019. The major business transactions (revenue activities) have taken place post the acquisition of the business by the Company i.e. after March 01, 2019.
Thyrocare is the peer of the Gian Life. It is currently available at P/E of 25x. Gian Life Care SME IPO is issuing shares at P/E of 15x. The valuation is not cheap, considering the size and operation of both companies. The RONW of Gian LIfe care is only 9% and Thyrocare is having RONW of 20%, which shows the Thyrocare has super return on net-worth as compared to Gian Life.
The financial data given in the DRHP is not enough to gauze the performance of the company. Therefore, nothing concrete can be concluded. If someone is really looking to invest in the diagnostic sector, then they can look for Dr. Lal Path and Thyrocare, which are available at good valuation and growing rapidly.
|Total Assets (In ₹ Millions)||797.07||782.38|
|Total Revenue (In ₹ Millions)||182.25||56.32|
|Profit After Tax (PAT) (In ₹ Millions)||33.85||6.94|
|Date & Time||QIB||NII||RII||Total|
|Day 1 - 31 Dec 2019||0.13||0.02||0.07|
|Day 2 - 1 Jan 2020||1.64||0.06||0.85|
|Day 3 - 2 Jan 2020||1.68||0.24||0.96|
|Day 4 - 3 Jan 2020||1.91||0.78||1.34|
Please click the link below to check the IPO allotment status.IPO Allotment Status
Gian Life Care Limited IPO will open on 31/12 and close on 03/01.
Gian Life Care Limited IPO will list on 13-Jan-2020.
The offer price of Gian Life Care Limited IPO is ₹22.
The lot size of Gian Life Care Limited IPO is 6000.
The Grey Market Premium (GMP) price of Gian Life Care Limited IPO is Not Available at the moment.
The Kostak price of Gian Life Care Limited IPO is Not Available at the moment.
The Subject to Sauda price for Gian Life Care Limited IPO is Not Available at the moment.
Please Leave Your Message